Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

CXCL16: a chemokine-causing chronic kidney disease.

Norlander AE, Saleh MA, Madhur MS.

Hypertension. 2013 Dec;62(6):1008-10. doi: 10.1161/HYPERTENSIONAHA.113.01954. Epub 2013 Sep 23. No abstract available.

2.

Critical role of CXCL16 in hypertensive kidney injury and fibrosis.

Xia Y, Entman ML, Wang Y.

Hypertension. 2013 Dec;62(6):1129-37. doi: 10.1161/HYPERTENSIONAHA.113.01837. Epub 2013 Sep 23.

3.

CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis.

Ma Z, Jin X, He L, Wang Y.

Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H815-21. doi: 10.1152/ajpheart.00948.2015. Epub 2016 Aug 5.

4.

TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.

Izquierdo MC, Sanz AB, Mezzano S, Blanco J, Carrasco S, Sanchez-Niño MD, Benito-Martín A, Ruiz-Ortega M, Egido J, Ortiz A.

Kidney Int. 2012 Jun;81(11):1098-107. doi: 10.1038/ki.2011.475. Epub 2012 Jan 25.

5.

Immature renal dendritic cells recruit regulatory CXCR6(+) invariant natural killer T cells to attenuate crescentic GN.

Riedel JH, Paust HJ, Turner JE, Tittel AP, Krebs C, Disteldorf E, Wegscheid C, Tiegs G, Velden J, Mittrücker HW, Garbi N, Stahl RA, Steinmetz OM, Kurts C, Panzer U.

J Am Soc Nephrol. 2012 Dec;23(12):1987-2000. doi: 10.1681/ASN.2012040394. Epub 2012 Nov 8.

6.

Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis.

Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N, Calixto S, Mackay M, Aranow C, Putterman C, Mohan C.

J Immunol. 2007 Nov 15;179(10):7166-75.

7.

CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis.

Chen G, Lin SC, Chen J, He L, Dong F, Xu J, Han S, Du J, Entman ML, Wang Y.

J Am Soc Nephrol. 2011 Oct;22(10):1876-86. doi: 10.1681/ASN.2010080881. Epub 2011 Aug 4.

8.

Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.

Wang C, Li Q, Zhen J, Xu Y, Sun S.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):15696-707. eCollection 2015.

9.

Importance of CXCL16 as a biomarker for granulocytapheresis in patients with Crohn's disease.

Nakase H, Uza N, Matsuura M, Chiba T.

Inflamm Bowel Dis. 2011 Oct;17(10):2211-2. doi: 10.1002/ibd.21657. Epub 2011 Mar 9. No abstract available.

PMID:
21391290
10.

The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.

Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E.

Cancer Res. 2008 Jun 15;68(12):4701-8. doi: 10.1158/0008-5472.CAN-08-0482. Retraction in: Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E. Cancer Res. 2011 Feb 1;71(3):1196.

11.

Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.

Diegelmann J, Seiderer J, Niess JH, Haller D, Göke B, Reinecker HC, Brand S.

Inflamm Bowel Dis. 2010 Nov;16(11):1871-81. doi: 10.1002/ibd.21306.

12.

The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.

Borst O, Münzer P, Gatidis S, Schmidt EM, Schönberger T, Schmid E, Towhid ST, Stellos K, Seizer P, May AE, Lang F, Gawaz M.

Circ Res. 2012 Oct 26;111(10):1297-307. doi: 10.1161/CIRCRESAHA.112.276444. Epub 2012 Aug 27.

13.

Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo.

Postea O, Koenen RR, Hristov M, Weber C, Ludwig A.

J Cell Mol Med. 2008 Sep-Oct;12(5A):1700-9. doi: 10.1111/j.1582-4934.2008.00223.x. Epub 2008 Jan 11.

14.

Increased renal iron accumulation in hypertensive nephropathy of salt-loaded hypertensive rats.

Naito Y, Sawada H, Oboshi M, Fujii A, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Morisawa D, Ohyanagi M, Tsujino T, Masuyama T.

PLoS One. 2013 Oct 8;8(10):e75906. doi: 10.1371/journal.pone.0075906. eCollection 2013.

15.

[Involvement of chemokine CXCL16 in myocardial infarction and its influence on phagocytic activity of macrophage in vitro].

Xiao Z, Zhang J, Zhang J, Wang L, Du J.

Zhonghua Yi Xue Za Zhi. 2014 Jan 21;94(3):218-22. Chinese.

PMID:
24731468
16.

Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats.

Schupp N, Kolkhof P, Queisser N, Gärtner S, Schmid U, Kretschmer A, Hartmann E, Oli RG, Schäfer S, Stopper H.

FASEB J. 2011 Mar;25(3):968-78. doi: 10.1096/fj.10-173286. Epub 2010 Dec 6.

PMID:
21135038
17.

Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease.

Guan T, Gao B, Chen G, Chen X, Janssen M, Uttarwar L, Ingram AJ, Krepinsky JC.

Am J Physiol Renal Physiol. 2013 Nov 15;305(10):F1466-76. doi: 10.1152/ajprenal.00057.2013. Epub 2013 Aug 14.

18.

CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.

Gutwein P, Abdel-Bakky MS, Doberstein K, Schramme A, Beckmann J, Schaefer L, Amann K, Doller A, Kämpfer-Kolb N, Abdel-Aziz AA, El Sayed el SM, Pfeilschifter J.

J Cell Mol Med. 2009 Sep;13(9B):3809-25. doi: 10.1111/j.1582-4934.2009.00761.x. Epub 2009 May 1.

19.

Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.

Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G.

Circ Heart Fail. 2009 Nov;2(6):624-32. doi: 10.1161/CIRCHEARTFAILURE.108.821074. Epub 2009 Sep 22.

20.

Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration.

Zhang L, Ran L, Garcia GE, Wang XH, Han S, Du J, Mitch WE.

Am J Pathol. 2009 Dec;175(6):2518-27. doi: 10.2353/ajpath.2009.090275. Epub 2009 Nov 5.

Supplemental Content

Support Center